NCBiotech News

Paris-based Cellectis has successfully dosed its first U.S. patient with its UCART22 allogeneic CAR T-cell therapy product candidate that it made in its new Raleigh facility.

There'll be job info galore at the free public Biomanufacturing and Process Development BioGrow Training and Education Symposium on Thursday, Feb. 9, from 12:30 to 5 p.m. at NCBiotech.

RTP gene therapy startup Opus Genetics has acquired the rights to two pre-clinical product candidates to treat inherited retinal diseases from New Jersey biopharm company Iveric Bio.

Catalent, a major CDMO with two key facilities in North Carolina, says will invest up to $40 million to add a third -- a Durham County campus that will create 201 jobs upon completion.

Believer Meats, an Israeli company that is commercializing cultivated meat made from animal cells, has announced plans to build a $123 million, 200,000-square-foot manufacturing facility in Wilson that will employ 100 people when fully operational three years from now.

Enzyvant and Altavant, wholly owned subsidiaries of Sumitovant Biopharma, are forming a Triangle-based rare-disease biopharma company.

FUJIFILM Corporation is investing $188 million in a cell culture media manufacturing facility in Research Triangle Park, adding more than 100 new jobs.

Michele Chang, the U.S. EDA’s deputy assistant secretary for policy, liked what she saw as she led a contingent to North Carolina’s Research Triangle area to review how partners were doing on their $25 million grant plans.

Seqirus, a global vaccine maker with a newly expanded manufacturing plant in Holly Springs, has signed a $30.1 million federal contract to produce a potential vaccine against avian flu.

Central Carolina Community College recently welcomed its first Biotechnology Pathway Navigator to give BioWork and biotechnology students a leg up when pursuing a career in biomanufacturing and the life sciences.

Johnston County commissioners have approved performance-based economic development incentives in support of anticipated new investments during the coming 12 years by global biomanufacturing giant Novo Nordisk.

Army veteran Diane Zambrano exemplifies how earning BioWork certification at Johnston Community College laid the groundwork for career steps leading to her dream job.

NightHawk Biosciences has announced plans to build a new advanced biosafety level 2 laboratory that will add biodefense and infectious disease capabilities at its Morrisville headquarters site.

ABEC, a Pennsylvania-based global provider of specialized products and services for biomanufacturing companies, will invest $11 million by the end of 2024 and hire some 250 people at a Wilson production facility.

Catalent is buying Greenville-based contract development and manufacturing organization (CDMO) Metrics Contract Services.